Product Reports Resources Pricing Login Book a demo

Illumina

Biotech & Life Sciences · San Diego, United States · Founded 1998 · IPO 2000

Integrated systems for genetic and biological analysis.

Valuation $32B
Revenue $4.61B
EBITDA $1.30B

Investors

12 investors on Illumina's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 8 investors entered at this stage
Dow
Tredegar Investments
CW Group Holdings
Chevron Technology Ventures
State Farm
Chase Capital Partners
The Tisch Family
Lombard Odier
Series B+ 4 investors entered at this stage
Venrock
ARCH Venture Partners
University of Utah
Tufts University

Global footprint

Where Illumina has talent and traffic

Workforce by country
49 countries with
team presence
🇺🇸 United States59%
🇸🇬 Singapore11.9%
🇬🇧 United Kingdom9.1%
🇮🇳 India3.2%
🇨🇳 China2.3%
Top 5 of 49 shown
Web traffic by country
830K monthly visits
across markets
🇺🇸 United States41.2%
🇬🇧 United Kingdom6.4%
🇯🇵 Japan3.8%
🇩🇪 Germany3.1%
🇹🇭 Thailand3%
Top 5 markets shown

Talent graph

The shape of Illumina's talent

Dealroom maps Illumina's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

79 standout operatorsDealroom-flagged across the org
92 AI specialistsincl. 52 core researchers
9,679 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Illumina's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$2.4B patent portfolio · 1,980 active families

Estimated portfolio value
$2.4B
7.4% of market cap · larger than top peer BioNTech ($788M)
1,980 active patent families
Where Illumina innovates BioinformaticsComputational biologyMolecular biologyNucleic acidNucleotide

Where Illumina concentrates vs peers

Each axis is a top-10 topic across Illumina and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Illumina's 145 investments and acquisitions.

Every disclosed deal where Illumina appeared as a backer or acquirer, 2006–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

145 deals across Illumina's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Illumina deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Illumina's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        145 of 145 deals

        Market sentiment

        What the market is saying about Illumina

        An AI-synthesized read of the highest-engagement posts about Illumina on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Illumina on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.